Sign In
Buy NDAQ
$82.49
-0.120 (-0.145%)
At Close: Jun 23, 2026
Nasdaq Bear Market: Buy the Dip on This "Magnificent Seven" Stock That's Down 29%
04:25am, Thursday, 10'th Apr 2025
The Nasdaq-100 and Nasdaq Composite indexes have officially entered bear market territory, down by more than 20% from their all-time highs. Many of their component stocks are down even more than that,
Tianci International, Inc. Announces Nasdaq Uplisting and Pricing of $7 Million Public Offering
08:00pm, Wednesday, 09'th Apr 2025
HONG KONG and RENO, Nev., April 09, 2025 (GLOBE NEWSWIRE) -- Tianci International, Inc. (the "Company” or “Tianci”), a global logistics service provider specializing in ocean freight forwarding,
Primis Financial Corp. Receives Nasdaq Notice Regarding Delayed 10-K Filing
05:00pm, Wednesday, 09'th Apr 2025
MCLEAN, Va. , April 9, 2025 /PRNewswire/ -- Primis Financial Corp. (NASDAQ: FRST) ("Primis" or the "Company") announced today that, as expected, it received a notice on April 3, 2025 (the "Notice") fr
Venus Concept Announces $1.1 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
04:35pm, Wednesday, 09'th Apr 2025
TORONTO, April 09, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has ente
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Wednesday, 09'th Apr 2025
BRISBANE, Calif., April 09, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on April 3, 2025, the Compensation Committee granted inducement awards consisting of no
Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date March 31, 2025
04:05pm, Wednesday, 09'th Apr 2025
NEW YORK, April 09, 2025 (GLOBE NEWSWIRE) -- At the end of the settlement date of March 31, 2025, short interest in 3,140 Nasdaq Global MarketSM securities totaled 13,072,444,217 shares compared with
1 "Magnificent Seven" Stock to Buy Hand Over Fist in the Nasdaq Bear Market
04:00pm, Wednesday, 09'th Apr 2025
As of market close on April 7, the Nasdaq Composite has fallen by 19% so far this year, falling further into bear market territory.
Nasdaq Index: Forecast for US Stocks Improves as Tech Rebounds, Dollar Weakens
01:40pm, Wednesday, 09'th Apr 2025
Tech stocks rebound, lifting US indices mid-session, while tariffs drive bond selloff and weaken the dollar. Traders eye earnings and Treasury auctions.
Here's 1 Nasdaq ETF to Consider Even as the Index Enters Into a Bear Market
09:54am, Wednesday, 09'th Apr 2025
Well, it's official: The Nasdaq Composite has entered bear territory. A bear market occurs when a major index drops over 20% from recent highs, and that's precisely what has happened with the Nasdaq C
Nasdaq Composite Futures Sink After China Retaliates: Apple Magnificent 7 Stocks Drop
08:37am, Wednesday, 09'th Apr 2025
One expectation for this earnings season is that you'll see many companies pull guidance amidst tariff uncertainty.
Edible Garden Regains Compliance with Nasdaq Bid Price Requirement
08:30am, Wednesday, 09'th Apr 2025
BELVIDERE, NJ, April 09, 2025 (GLOBE NEWSWIRE) -- Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leader in controlled environment agriculture (CEA),
Nasdaq Bear Market: 2 Artificial Intelligence (AI) Stocks to Confidently Buy With $650
04:56am, Wednesday, 09'th Apr 2025
The Nasdaq Composite (^IXIC -2.15%) includes almost every company listed on the Nasdaq stock exchange, so it's often a good proxy for the performance of the broader technology industry. As of the clos
The Nasdaq Plunged 10% While Palantir Soared In Q1. Here's Why.
06:41pm, Tuesday, 08'th Apr 2025
The market saw red for much of the first quarter of 2025. Shares of Palantir Technologies (PLTR -0.62%), however, bucked the trend.
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
05:30pm, Tuesday, 08'th Apr 2025
SAN DIEGO--(BUSINESS WIRE)--Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pul
Blink Charging Co. Announces Notification from Nasdaq regarding late filing of Form 10-K
05:25pm, Tuesday, 08'th Apr 2025
Bowie, MD., April 08, 2025 (GLOBE NEWSWIRE) -- Blink Charging Co. (NASDAQ: BLNK) (“Blink” or the “Company”), a leading global owner, operator, provider, and manufacturer of electric vehicle
